baber/WOPTO huggingface dataset:
Patent IL-146719-A0 (IL)
Title: Ink cartridge for compact printer system
IPC: B41J2/175
Filed: 2000-05-24
Abstract: A modular camera and printer is disclosed. A camera module is provided having an image sensor for capturing an image in a RGB format. The camera module also has a central processing unit with program memory for storing program steps for execution by the central processing unit to operate the camera module, and an image storage memory for storing the captured image in the RGB format. An image processing unit of the camera module is in communication with the image storage memory and transforms image data in the image storage memory into a L*a*b* format. The camera module also has a serial bus for outputting transformed image data in the L*a*b* format. A printer module is provided also having a serial bus in communication with the serial bus of the camera module. The printer module receives the image data from the camera module in the L*a*b* format, converts the image data to a color space of the printer module, and then prints the image data on a printhead.
Patent IL-146783-A0 (IL)
Title: Herbicidal emulsifiable concentrate compositions of dinitroaniline and oxyacetamide herbicides
IPC: A01N33/18
Filed: 2000-06-20
Abstract: The present invention provides herbicidal emulsifiable concentrate compositions of dinitroaniline herbicides and oxyacetamide herbicides. The compositions utilize phosphoric acid as a stabilizing agent to prevent degradation of the oxyacetamide herbicide component during storage.
Patent IL-150294-A0 (IL)
Title: Antidiabetic preparation for oral administration
IPC: A61P3/10
Filed: 2000-12-27
Abstract: An oral anti-diabetic preparation for controlling post-prandi
Patent IL-152599-A0 (IL)
Title: A process for the synthesis of sucrose-6-esters
IPC: B01J31/12
Filed: 2001-07-19
Abstract: There is described a process for the synthesis of a sucrose-6-ester comprising: (a) reacting a mixture comprising sucrose and a polar aprotic solvent with an organotin-based acylation promoter, while adding a solvent capable of removing water by co-distillation, and removing water by co-distillation, to afford a first reaction mixture which is substantially free from water, followed by (b) adding a carboxylic anhydride to said first reaction mixture to afford a second reaction mixture, and maintaining said second reaction mixture at a temperature and for a period of time sufficient to produce a sucrose-6-ester, characterised in that step (a) is performed at a temperature of from 85 to 125° C. and at a pressure of from 20 to 80 kPa. In the most preferred embodiment, the polar aprotic solvent is DMF, the solvent capable of removing water by co-distillation is cyclohexane, the organotion-based acylation promoter is a 1,3-diacyloxy-1,1,3,3-tetrabutyldistannoxane, and step (a) is performed at approximately 97° C., and approximately 50 kpa, until the weight ratio of tin to water in the first reaction mixture is greater than about 26, when the tin content is measured by X-Ray Fluoresence Analyzer, and the water content is measured by the Karl-Fischer method.
Patent IL-153124-A0 (IL)
Title: Solid mucoadhesive composition
IPC: A61K9/00
Filed: 2002-11-27
Abstract: An adhesive solid therapeutic composition containing an active ingredient which is an extract of a plant selected from the group consisting of Sambucus nigra, Centella asiatica and Echinacea purpurea, or mixtures thereof and excipients, said excipients comprising (i) a bulk ingredient (ii) an adhesive polymer of acrylic acid and (iii) polyyinylpyrrolidone.
Patent IL-158351-A0 (IL)
Title: Method and device for continuous production of glass-sheathed metal wires
IPC: C03B37/026
Filed: 2002-04-16
Abstract: The device and process allow for continuous processing of metal wire sheathed in glass ( 10 ) of considerable length. Normally a feed pipe ( 15 ) containing all the necessary metal, itself placed into a glass tube ( 20 ), so as to continuously supply a bead ( 14 ) to the lower part of the glass tube ( 20 ). Heat from a first inductor ( 23 ) around the glass tube ( 20 ) and a second inductor ( 24 ) under the glass tube ( 20 ) allow to maintain a bead ( 14 ) at a stable temperature and in a continuous manner and to obtain the continuous drawing process of a metal wire sheathed in glass ( 10 ).
Patent IL-160692-A0 (IL)
Title: Malleable cryosurgical probe
IPC: A61B17/00
Filed: 2002-09-19
Abstract: The malleable cryosurgical probe includes a cryostat assembly and a cryoprobe assembly. The cryostat assembly includes an elongated shaft assembly having at least one malleable segment thereof and a closed distal end. The shaft assembly includes at least one freezing portion, at least one thermally insulated portion and a thermally insulating element positioned about the thermally insulated portion. A cryostat is operably associated with the elongated shaft assembly. It includes a cryostat inlet for receiving gas entering the cryostat, a cryostat outlet and a heat exchanger positioned between the cryostat outlet and the cryostat inlet. The heat exchanger receives gas from the cryostat inlet and provides heat transfer between gas flowing within the cryostat and fluid exterior thereto. At least one Joule-Thomson nozzle is in fluid communication with the cryostat outlet. The at least one Joule-Thomson nozzle expands gas expelled therefrom. The expanded cold fluid communicates with the freezing portion to provide cooling thereof. The cryoprobe assembly includes a handle assembly for supporting the cryostat assembly and a fluid supply line assembly connectable to a fluid source at one end and to the cryostat inlet at a second end. The heat exchanger is positioned at a location longitudinally spaced from the freezing portion(s).
Patent IL-161581-A0 (IL)
Title: Pyrazolidinone derivatives and their use
IPC: A61P29/00
Filed: 2002-10-23
Abstract: The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteoporosis and other destructive bone disease or disorder, and other diseases and disorders associated with the prostaglandin EP2 and/or EP4 receptors.
Patent IL-181218-A0 (IL)
Title: Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
IPC: A61K39/00
Filed: 2007-02-08
Abstract: A novel gene 58P1D12 and its encoded protein, and variants thereof, are described wherein 58P1D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 58P1D12 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 58P1D12 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 58P1D12 can be used in active or passive immunization.
Patent RO-131787-A0 (RO)
Title: Process for preparing hydrogen-rich gases by catalytic reforming of glycerin at low temperatures
Inventor: LAZĂR MIHAELA DIANA
IPC: C01B3/38
Filed: 2016-07-22
Abstract: The invention relates to a process for preparing hydrogen-rich gases from glycerin. According to the invention, the process consists in catalytically reforming glycerin with water vapours at a temperature of 550°C and atmospheric pressure, in the presence of Ni/oxide-AlOtype catalysts prepared by successive impregnation, the oxide being CaO or LaO, in a concentration of 6% by mass.
Patent RO-132484-A0 (RO)
Title: Homogenous superficially-active non-ionic-cationic structures and process for obtaining the same
Inventor: JIANU IONEL CĂLIN
IPC: C11D1/835
Filed: 2017-08-09
Abstract: The invention relates to homogenous cationic acyclic non-ionic structures and to a process for obtaining the same. According to the invention, the claimed structures are of the type of N-methyl-N-benzyl N-alkyl-β octylphenoxy ethylammonium chloride and N-methyl-N-benzyl-N-alkyl-β octylphenylpolyethyleneoxy ethylammonium chloride. According to the invention, the process consists of the stages of: synthesis of homogenous polyoxyethylene chains, PEGylation/cyanoethylation of p-octylphenols as such and polyethoxylated, partial acid hydrolysis of primary homogenous β -p-octylphenyloxy- and/or polyethyleneoxy ethylamines, preparation of the respective tertiary ethylamines, followed by the preparation of N-methyl-N-alkyl-N-benzyl-N-β -p-octylphenoxy- and/or polyethyleneoxy-ethylammonium chlorides, all stages occurring in the presence of the usual phase transfer catalysts.
Patent RO-133868-A0 (RO)
Title: Self-adhesive jewel with crystals
Inventor: JUCHI CĂTĂLINA DIANA
IPC: G09F3/10
Filed: 2019-09-26
Abstract: The invention relates to a self-adhesive jewel with crystals, intended for decoration of various objects, such as phone, laptop computer, tablet, shoes or purses. According to the invention, the jewel consists of a first layer (1) made of a plurality of thermoadhesive crystals, either single-coloured or of various colours, arranged on a transfer foil according to a certain pattern, a second layer (2) consisting of a composite textile material without warp or weft, a double-adhesive connecting layer (3) which contains a strong-fixing acrylic adhesive on both the upper and the lower face, a layer (4) consisting of a flexible material, such as a self-adhesive vinyl foil and a last layer (5) made of wax paper on which a jewel is fixed and which permits it to be easily detached in order to be used.
Patent RO-135994-A0 (RO)
Title: Highly efficient cryogenic source of liquid nitrogen vapour
Inventor: BRĂTFĂLEAN RADU TIBERIU
IPC: F17C9/02
Filed: 2022-04-21
Abstract: The invention relates to a highly efficient cryogenic source of liquid nitrogen vapour. According to the invention, the cryogenic source comprises a cylinder (1) for storing gaseous nitrogen, equipped with a valve (2) for closing and opening the cylinder, a pressure reducer (3) being connected at the outlet of the valve (2), to control the pressure of the nitrogen delivered from the cylinder (1) through a metal tube, to a dewar vessel (7) containing liquid nitrogen, the metal tube continuing inside the dewar vessel in the form of a spiral placed at the bottom of the vessel, which constitutes a heat exchanger (8) with the role of facilitating the exchange of heat between the supplied gaseous nitrogen and the liquid nitrogen within the dewar vessel (7), the cryogenic nitrogen gas formed in the dewar vessel being discharged through an outlet metal tube (5).
Patent MW-1084-A1 (MW)
Title: A process for the manufacture of nitric acid esters
IPC: C07C201/00
Filed: 1984-06-07
Abstract: The invention concerns a process for the preparation of nitric acid esters of organic hydroxy compounds by reacting an organic hydroxy compound with nitric acid in the presence of sulphuric acid and in a solvent, followed by separating off the spent acid, substantially neutralizing the residual acidity of the organic solution, and removing solvent to leave the organic nitrate. From 95% to 220% of the stoichiometric requirement of nitric acid for complete nitration is used. The mole ratio of water to sulphuric acid at the end of the reaction is from 0,2:1 to 2,5:1. From 200 to 2000 ml of solvent per mole of hydroxy group is present. Yields of at least 92% are obtained. The invention is particularly suitable for the preparation of alkyl nitrates, alkylene or polyalkylene glycol, monoalkyl ether mononitrates, alkylene or polyalkylene glycol dinitrates, diol nitrates, nitrates containing homocyclic or heterocyclic rings, or nitrates derived from polyols.
Patent MA-27174-A1 (MA)
Title: Derives de nicotinamide utiles comme inhibiteurs de pde4.
Inventor: BAILEY SIMON
IPC: C07D451/10
Filed: 2004-08-03
Abstract: DEPOSANT Société dite : PFIZER INC. REVENDICATION DE PRIORITES GB	11 Février 2002	0203196.1 GB	10 Septembre 2002	0220999.7 GB	21 Octobre 2002	0224453.1 GB	20 Novembre 2002	0227139.3 Voir en annexe le titre de l'invention et le texte de l'abrégé Dérivés de nicotinamide utiles comme inhibiteurs de PDE4 La présente invention concerne des dérivés de nicotinamide de formule (1) et des procédés pour la préparation de, des intermédiaires utilisés dans la préparation de, des compositions contenant, et les utilisations de, ces dérivés. Les dérivés de nicotinamide conformes à la présente invention sont des inhibiteurs de phosphodiestérase 4 et sont utiles dans de nombreuses maladies, de nombreux troubles et de nombreuses affections, en particulier des maladies, troubles et affections inflammatoires, allergiques et respiratoires, ainsi que des plaies.
Patent MA-27453-A1 (MA)
Title: Indazoles, benzothiazoles et benzoisothiazoles, leur preparation et leurs utilisations
Inventor: TEHIM ASHOK
IPC: C07D453/02
Filed: 2005-04-12
Abstract: La présente invention concerne généralement le domaine des ligands pour les récepteurs de l'acétylcholine nicotiniques (nAChR), l'activation des nAChR et le traitement des états pathologiques associés aux récepteurs de l'acétylcholine nicotiniques défectueux ou défaillants, spécialement du cerveau. En outre, cette invention concerne de nouveaux composés (indazole et benzothiazole), qui agissent en tant que ligands pour le sous-type nAChR (alpha)-7, des procédés de préparation de tels composés, des compositions contenant de tels composés, et des procédés d'utilisation de ceux-ci.
Patent MA-27835-A1 (MA)
Title: Methodes pour le traitement de l'atherosclerose, des dyslipemies et conditions apparentees et compositions pharmaceutiques
Inventor: CHENG KANG
IPC: A61K31/437
Filed: 2005-11-09
Abstract: EXTRAIT Une méthode pour le traitement de l'athérosclérose est révélée oé l'acide nicotinique ou autre agoniste du récepteur de l'acide nicotinique est administré à un patient en combinaison avec un antagoniste du récepteur de DP. L'antagoniste du récepteur de DP est administré pour réduire, prévenir ou éliminer la bouffée congestive qui pourrait autrement se produire.
Patent MA-20150146-A1 (MA)
Title: Procédé de métallisation en cuivre destiné à la fabrication d'un circuit intégré en utilisant la technologie wafer level packaging 3d
Inventor: SAID ZAHRAOUI
IPC: H01L23/538
Filed: 2013-10-14
Abstract: Procédé de métallisation 'à base de,cuivre de ligne de connexion (rdl) 32 et de vias traversant 34 (fig .La) destiné à la fabrication d'un circuit intégré en généralet d'un capteur d'image en particulier en utilisant ta technologie wafer level packaging 3d , permettant de réduire le co,ût defabrication et d'avoir une meilleure performance électrique au niveau du dit capteur d'image 1 notamment pour la réalisation des interconnexions dans des circuits intégrés en trois dimensions.
Patent MA-20150098-A1 (MA)
Title: Procédé de réalisation d'une tôle à revêtements znalmg comprenant l'application d'une solution acide et d'un adhésif, tôle et assemblage correspondants
Inventor: RICHARD JOËLLE
IPC: C23C22/06
Filed: 2013-04-25
Abstract: Ce procédé comprend au moins des étapes de : - fourniture d'un substrat (3) en acier présentant deux faces (5) revêtues par trempe du substrat (3) dans un bain, - application d'une solution acide de ph compris entre 1 et 4 sur les surfaces extérieures (15) des revêtements métalliques (7), - application d'un adhésif (13) localement sur au moins une surface extérieure (15) d'un revêtement métallique (7).
Patent MA-37789-A1 (MA)
Title: Inhibiteurs de la famille mir-15 de micro-arn
Inventor: VAN ROOIJ EVA
IPC: C12N15/11
Filed: 2013-06-21
Abstract: L'invention procure des oligonucléotides modifiés de manière chimique capables d'inhiber l'expression (par exemple, l'abondance) de miarn de la famille mir-15, y compris mir-15a, mir-15b, mir-16, mir-195, mir-424 et mir-497. L'invention fournit, dans certains modes de réalisation, des oligonucléotides capables d'inhiber, d'une façon spécifique, l'expression ou l'abondance de chacun des mir-15a, mir-15b, mir-16, mir-195, mir-424 et mir-497. L'invention fournit en outre des compositions pharmaceutiques qui comprennent les oligonucléotides, et des procédés destinés à soigner des patients qui présentent des états ou des troubles qui se rapportent à, ou qui impliquent, un miarn de la famille mir-15, tel qu'un état cardiovasculaire. Dans divers modes de réalisation, les oligonucléotides procurent un ou plusieurs des avantages suivants : dilution, efficacité de délivrance, spécificité cible, toxicité et/ou stabilité.
Patent MA-53518-A1 (MA)
Title: Methode et systeme de gestion de flux de marchandises a base de generation dynamique de code visuel et de synchronisation integree de factures dematerialisees
Inventor: HAFFANE YOUNES
IPC: G06Q40/00
Filed: 2021-06-01
Abstract: Une méthode et un système pour faciliter la commande, la réception et la facturation dématérialisée de marchandises entre deux parties prenantes munies de terminaux informatiques mobiles ou fixes. La méthode comporte la sélection de la marchandise par le premier utilisateur sur son terminal (téléphone mobile, terminal de paiement dédié, ordinateur ou tout autre outil informatique), un enregistrement informatique comportant les détails de la commande et une génération dynamique de documents comportant le détail de la commande et un code visuel sur le serveur de stockage distant. Une fois la marchandise livrée par le deuxième utilisateur, le premier utilisateur utilise son terminal pour scanner le code visuel apposé aux documents générés automatiquement ci-dessus. Ces documents sont présentés par le deuxième utilisateur en version papier ou directement depuis son terminal. Suite à cette opération de scan, une copie digitale des documents (en totalité ou en partie) est chargée sur le terminal du premier utilisateur. Des enregistrements informatiques sont créés ou mis à jour sur le serveur de stockage distant pour désigner la quantité de chaque produit commandé dans le stock du premier utilisateur. Des enregistrements informatiques sont mis à jour sur le serveur de stockage distant pour désigner la quantité de chaque produit commandé dans le stock du deuxième utilisateur. Les stocks des deux utilisateurs sont mis en ligne et peuvent être accédés depuis un quelconque terminal en ligne.
Patent UY-27254-A1 (UY)
Title: Drogas peptidicas antiangiogénicas
Inventor: HENKIN JACK
IPC: C07K1/14
Filed: 2002-04-10
Abstract: Péptidos que son útiles para inhibir la angiogénesis. También se describen composiciones y métodos que inhiben la angiogénesis en un mamífero.
Patent UY-27587-A1 (UY)
Inventor: YUN-XING CHENG
IPC: C07D333/48
Filed: 2002-12-17
Abstract: Compounds of formula (I) or (II) wherein R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>, R<SUB>4</SUB>, W, Q, G, X and Y are as defined in the specification, as well as salts, enantiomers thereof and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
Patent UY-28466-A1 (UY)
Title: Derivados de piperazina
Inventor: MIDDLETON DONALD STUART
IPC: C07D217/26
Filed: 2004-08-12
Abstract: Esta invención se refiere a un compuesto de fórmula (I) o sales, solvatos o derivados farmacéuticamente aceptables del mismo, donde R1 a R5 se definen en la descripción, y a procedimientos para la preparación de los mismos, a intemedios usados en sus preparaciones, a composiciones que los contienen y a los usos de tales derivados. Los compuestos de la presente invención inhiben la interacción de gp120 con CD4 y, por lo tanto, son útiles en el tratamiento del VIH, de una infección retroviral genéticamente relacionada con el VIH, o del SIDA.
Patent UY-28653-A1 (UY)
Title: N-alquil pirroles como inhibidores de la hmg-coa reductasa
Inventor: BRATTON LARRY DON
IPC: C07D207/34
Filed: 2004-12-03
Abstract: Se proporcionan compuestos inhibidores de la HMG Co-A reductasa útiles como compuestos hipocolesterolémicos e hipolopedémicos. También se proporcionan composiciones farmacneuticas de los compuestos. También se proporcioann métodos para fabricar y métodos para usar los compuestos.
Patent UY-29550-A1 (UY)
Title: Derivados de (sulfamoil-alquil)-amida de ácido heteroaril-carboxílico como inhibidores del factor xa
Inventor: NAZARC DR MARC
IPC: C07D207/30
Filed: 2006-05-19
Abstract: La presente invención se refiere a compuestos derivados de (sulfamoil-alquil)-amida de ácido heteroaril-carboxílico como inhibidores del factor Xa, de fórmula I, en los que los sustituyentes y radicales tienen los significados indicados en las reivindicaciones. Presentan un fuerte efecto antitrombótico; son adecuados para la terapia y profilaxis de trastornos cardiovasculares; son inhibidores reversibles de las enzimas de coagulacíón de la sangre, el factor Xa. La invención se refiere a procedimientos para preparar los compuestos de la fórmula I, a su uso como principios activos en productos farmacéuticos, y a preparaciones farmacéuticas que los contienen.
Patent UY-29934-A1 (UY)
Title: Composicion edulcorante de alta intensidad con ácido graso y composiciones endulzadas con ella
Inventor: CHEN YOULUNG
IPC: A23L27/10
Filed: 2006-11-20
Abstract: Composiciones edulcorantes funcionales que comprenden edulcorantes naturales y/o sintéticos no calóricos o hipocalóricos de alta potencia y los métodos para hacerlos y usarlos. En particular, la invención refiere a diferentes composiciones edulcorantes funcionales que comprenden al menos un edulcorante natural y/o sintético no calórico o hipacalórico de alta potencia, al menos una composición para mejorar el sabor dulce y al menos un ingrediente funcional como, por ejemplo, un ácido graso.
Patent UY-30515-A1 (UY)
Title: Formulacion farmaceutica y su uso, y dispositivo de dosificacion controlada que contiene el mismo
Inventor: QAZI MUHAMMAD WASEEM T
IPC: A61M11/00
Filed: 2007-07-31
Abstract: Formulacion farmacéutica para absorber por la mucosa oral incluyendo una cantidad efectiva de un agente farmacéutico en forma de micela combinada, al menos un compuesto formador de micela seleccionado del grupo de sulfato alquilo de metal alcalino y monooleato de sorbitan polioxietileno, un copolímero bloque de polioxietileno y polioxipropileno, al menos un compuesto formador de micela adicional y un disolvente adecuado. Dispensador de dosis graduado conteniendo la formulacion y un método de administracion de insulina con un dispensador de dosis graduado que incluye administrar dosis multiples de una formulacion que contiene insulina antes y después de cada comida.
Patent UY-31046-A1 (UY)
Title: Derivados sustituidos de n-(3,4-dihidro-2h-cromen-3-il)formamida y n-(1, 2,3 ,4-tetrahidronaftalen-2-il)formamida, sales de los mismos, composiciones que los contienen, procedimientos para su preparacion y aplicaciones
Inventor: SKOGHOLM KARIN
IPC: A61K31/415
Filed: 2008-04-23
Abstract: La presente invencion se relaciona con nuevos compuestos de formula I y con la composicion farmacéutica que contiene dichos compuestos en la terapia. La presente invencion se relaciona además con el proceso para la preparacion de dichos compuestos y con los nuevos productos intermedios utiles en la preparacion de los mismos.
Patent ES-174256-A1 (ES)
Title: Un procedimiento para la obtencion de cetonas de piperidilo
IPC: C07D211/32
Filed: 1946-06-11
Abstract: Procedimiento para la obtención de cetonas de piperidilo caracterizado porque sobre un éster de ácido 4-arilo-piperidina-(4)-carboxílico se hace reaccionar una combinación metalorgánica se descompone el producto de la reacción y se aisla la cetona de 4-arilo-piperidilo-(4) obtenida.